Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

EJMCR. 2023; 7(9): 176-179


Thromboembolic phenomenon to bilateral lower limbs is a catastrophic complication of blood culture-negative infective endocarditis

Razif Ismail, Rosnelifaizur Ramely, Mohd Shakirin Pairan, Wan Yus Haniff Wan Isa.




Abstract

Background: Blood culture-negative infective endocarditis (BCNIE) refers to infective endocarditis (IE) with negative microorganism growth using usual blood culture method. It poses dilemma in terms of diagnosis, associated complication, and treatment. The study aims to highlight the occurrence of acute bilateral lower limb ischemia in BCNIE and its management approach.
Case presentation: We present a BCNIE patient who developed acute bilateral lower limb ischemia, Rutherford stage 2b despite on course of antibiotic treatment. Patient underwent emergency bilateral open femoral embolectomy and right profundaplasty. A full six-weeks course of antibiotics and short-term anticoagulant successfully reverse the acute ischemic event.
Conclusion: This case highlighted that despite the rarity of BCNIE causing limb ischemia, it can still occur due to significant risk factors. The early recognition of acute limb ischemia and prompt treatment are deemed important in saving the threatened limb from being amputated.

Key words: endocarditis, embolectomy, limb salvage, mitral valve insufficiency, thromboembolism.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.